Biomics Biopharma (ASX:BBM) Days Sales Outstanding : 0.00 (As of . 20)

View and export this data going back to 2017. Start your Free Trial

What is Biomics Biopharma Days Sales Outstanding?

Biomics Biopharma's average Accounts Receivable for the six months ended in . 20 was A$0.00 Mil. Biomics Biopharma's Revenue for the six months ended in . 20 was A$0.00 Mil.

The historical rank and industry rank for Biomics Biopharma's Days Sales Outstanding or its related term are showing as below:

ASX:BBM's Days Sales Outstanding is not ranked ^*
in the Biotechnology industry.
Industry Median: 72.67
* Ranked among companies with meaningful Days Sales Outstanding only.

Biomics Biopharma's Days Sales Outstanding stayed the same from . 20 (0.00) to . 20 (0.00).

Biomics Biopharma Days Sales Outstanding Historical Data

The historical data trend for Biomics Biopharma's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biomics Biopharma Days Sales Outstanding Chart

Biomics Biopharma Annual Data

Trend

Days Sales Outstanding

Biomics Biopharma Semi-Annual Data

Days Sales Outstanding

Competitive Comparison of Biomics Biopharma's Days Sales Outstanding

For the Biotechnology subindustry, Biomics Biopharma's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Biomics Biopharma's Days Sales Outstanding Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Biomics Biopharma's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where Biomics Biopharma's Days Sales Outstanding falls into.

Biomics Biopharma Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Biomics Biopharma's Days Sales Outstanding for the fiscal year that ended in . 20 is calculated as

	Days Sales Outstanding (A: . 20 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: . 20 )	+	Accounts Receivable (A: . 20 ))	/	count )	/	Revenue (A: . 20 )	*	Days in Period
=	( (	+	)	/	1 )	/		*	365
=	0					/		*	365
=	N/A

Biomics Biopharma's Days Sales Outstanding for the quarter that ended in . 20 is calculated as:

	Days Sales Outstanding (Q: . 20 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: . 20 )	+	Accounts Receivable (A: . 20 ))	/	count )	/	Revenue (A: . 20 )	*	Days in Period
=	( (	+	)	/	1 )	/		*	365 / 2
=	0					/		*	365 / 2
=	N/A

Biomics Biopharma (ASX:BBM) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.

Biomics Biopharma Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of Biomics Biopharma's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.

Biomics Biopharma (ASX:BBM) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Biomics Biopharma Ltd (ASX:BBM) » Definitions » Days Sales Outstanding

Comparable Companies

ASX:G88 ASX:ELS ASX:BHD ASX:IBX ASX:ZEN ASX:OLI ASX:KPG ASX:CAN ASX:MPW ASX:CQG ASX:OCA

Traded in Other Exchanges

N/A

Address

1 Macquarie Place, Level 36, Gateway Tower, Sydney, NSW, AUS, 2000

Website

http://www.biomics.com

Biomics Biopharma Ltd is a near-clinical-stage biopharmaceutical company in developing and commercialising double stranded ribonucleic acid (dsRNA) based innovative products for unmet medical needs.

Biomics Biopharma (ASX:BBM) Headlines

No Headlines